5-amino-1mq 5mg reconstitution (5mg) 5-Amino-1MQ Research Material | Modern

The compound is not FDA-approved for human use and is sold for research purposes only

Simultaneously, NAD+ levels increased by 1.2 to 1.6 fold compared to untreated cells

Third-party verification eliminates conflict of interest in quality assessment and provides researchers with independent confirmation of compound specifications

Published Research on 5-Amino-1MQ Foundational DIO Mouse Study Neelakantan et al., Biochemical Pharmacology (2018) This paper introduced 5-Amino-1MQ as a selective and membrane-permeable small molecule inhibitor of NNMT and tested it in 3T3-L1 adipocytes and in male C57BL/6J mice maintained on a high-fat diet

These findings suggest that NNMT is a positive modulator of hepatocyte gluconeogenesis